News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardioDx, Inc.’s Leadership to Speak at the 5th Annual Personalized Medicine World Conference


1/28/2013 6:20:56 AM

CardioDx, Inc. announced today that President and CEO, David Levison, and Chief Medical Officer, Mark Monane, M.D., will present at the 5th Annual Personalized Medicine World Conference (PMWC) on Tuesday, January 29, 2013 in Mountain View, CA. Mr. Levison will provide a company perspective on the reimbursement pathway for molecular diagnostic tests, and Dr. Monane will present an overview of Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES